Podcasts about bioeconomy

In this episode, David, Chris, and Mark reflect on relevant and timely takeaways from recent episodes and what they tell us about the evolving sustainability agenda. It is a packed review and touches upon just transition, competitiveness, affordability, climate adaptation, corporate accountability, and the emerging bioeconomy.

In this episode, Chris and Mark speak with Marcelo Behar, COP30 Special Envoy for Bioeconomy. They discuss the origins and opportunities of the bioeconomy and how this pulls together all three COP processes (climate, biodiversity, and desertification), with implications and opportunities for business.

WTiN speaks with Carla Silva, director of chemistry and biotechnology at the Technological Centre for the Portuguese Textile and Clothing Industry (CITEVE).CITEVE promotes innovation, sustainability, technological excellence and competitiveness across Europe's textile and apparel sector. Based in Portugal the organisation has been running a project to shirt the textile and apparel sector toward sustainable, circular and biobased models.be@t (Bioeconomy for Textiles and Clothing) is a EU€138m Portuguese initiative running from July 2022 to the end of 2026 with backing from Portugal's Recovery and Resilience Plan and the European Union.In this episode Silva speaks about how Be@t brings together 56 entities in search of solutions for the conversion of the textile and clothing sectors on topics such as traceability and transparency, ecodesign and ecoengineering, impact and new sustainability metrics.She touches upon what the project has achieved and what this means for Portuguese manufacturing, and the wider European landscape. For more information please visit bioeconomy-at-textiles.com and citeve.pt.

In this episode, ATLVets welcomes Ed You, a former FBI Supervisory Special Agent with more than 20 years of experience in counterterrorism, biodefense, and emerging technologies. With a background in biochemistry, molecular biology, cancer research, and national security, Ed has advised the FBI, HHS, the Office of the Director of National Intelligence, the White House, and the U.S. delegation to the Biological Weapons Convention.Drawing from decades of experience, Ed explains why biotechnology, artificial intelligence, and data are reshaping national security, economic competitiveness, and the future of innovation.Chapter Segment:00:00 – Welcome & Speaker Introduction02:20 – From Biochemist to FBI Special Agent04:20 – Biological Threats & National Security09:00 – Operation Warp Speed10:45 – The Global Biotech Race12:30 – Modern Biological Threats15:00 – AI, Data & Biotechnology18:45 – America's Innovation Challenge20:15 – The Value of Data22:30 – China & Strategic Competition26:30 – The Bioeconomy29:40 – Opportunities for Entrepreneurs33:00 – AI Beyond the Hype37:00 – Audience Q&A38:25 – Biomanufacturing & Supply Chains42:15 – Biotechnology & Global Influence44:30 – Preparing the Next Generation47:10 – CRISPR & Gene Editing49:55 – The Future of Biosecurity51:30 – Closing RemarksIf you enjoyed this conversation, be sure to like, subscribe, and share this episode with someone interested in leadership, national security, biotechnology, or emerging technologies.Have a question or perspective on the future of AI, biotech, or the bioeconomy? Leave it in the comments—we'd love to continue the discussion.

Key TakeawaysBRAIN Biotech AG Elevator Pitch PresentationIn this seat11a Elevator Pitch, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company's business model, biotechnology platform, and long-term growth strategy.Biotechnology Platform for Sustainable Industrial SolutionsBRAIN Biotech develops enzyme products, microorganisms, and biological solutions that help customers replace conventional industrial processes with more sustainable biotechnology-based alternatives. The company serves customers across food, beverage, life sciences, proteins, dairy, and other specialty industrial markets through its integrated biotechnology platform.Two Complementary Business PillarsThe business is built around two complementary pillars. The BRAINBiocatalysts division develops and produces specialty enzymes and microbial solutions while providing contract research and manufacturing services. The BRAINBioIncubator focuses on breakthrough innovation projects, strategic participations, and pharmaceutical royalty opportunities that have the potential to create significant additional value over time.Balanced Business Model and Financial PerformanceManagement explains how this combination creates a balanced business model, generating profitable operating revenues while maintaining exposure to higher-value innovation projects. During FY 2024/25, BRAIN Biotech generated approximately €45.4 million in annual revenue, €4.4 million adjusted EBITDA, and approximately €4.2 million in recurring revenues, providing a solid financial foundation for future growth.Medium-Term Growth Targets and Expansion StrategyLooking ahead, the company has set ambitious medium-term objectives presented at its 2024 Capital Markets Day. Within its BRAINBiocatalysts division, management targets €100 million in revenue together with an adjusted EBITDA margin of 15%, supported by organic growth and acquisitions. At the same time, BRAINBioIncubator continues to offer additional upside through the commercialization of innovative biotechnology projects.Long-Term Growth Drivers in Industrial BiotechnologyThe presentation also explains how BRAIN Biotech benefits from long-term structural trends including sustainable manufacturing, biologization of industrial processes, growing demand for specialty enzymes, and increasing adoption of biological solutions across multiple industries. Management's long-term ambition is to establish BRAIN Biotech as one of the Top 10 global enzyme companies. ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Florida agriculture quietly underpins everyday life in the Sunshine State, shaping everything from grocery prices and water quality to how communities bounce back after a hurricane. In this episode of the Climate Correction Podcast, host Shannon Maganiezin sits down with the team behind the newly released report, Voices of Florida Farmers: Building a Circular Bioeconomy, to explore how the state's farmers, ranchers, foresters, and aquaculturists are producing more with less land, water, and resources, while keeping food affordable and local economies strong.  Leading the conversation is Courtney Girgis, the report's lead author, who grew up on a beef cattle, corn, and soybean farm in northern Missouri and now writes about agriculture from her family's small-acreage farm in Oklahoma. Courtney unpacks what a "circular bioeconomy" means in practice: an approach to agriculture that moves away from the linear "make, use, waste" model and instead keeps nutrients, water, and materials cycling, starting with healthy soil and extending outward into partnerships across the food system.  Joining her are three of the Florida producers featured in the report. Beaver Yoder, a Florida Panhandle cattle rancher, partners with neighboring crop farmers to graze his herd on cover crops between cash crop seasons, a practice that builds soil health, fertilizes fields, and creates a new revenue stream for everyone involved. Lanette Sobel, founder of Fertile Earth Worm Farm (now the largest commercial composting operation in South Florida), works across a wide network of distributors, food pantries, and farms to make sure food scraps go to their "highest and best use," feeding people first, then animals, then soil. Timothy Solano, a second-generation clam farmer and operations manager at Cedar Key Aquaculture Farms, raises clams that filter pollutants like nitrogen and carbon from Florida's coastal waters before being harvested for sale at Costco and Whole Foods. The clams' crushed shells go on to repair roads and surface local school parking lots.  Together, the conversation moves from real-world examples of circularity on the farm and on the water, to the regulatory and economic obstacles that keep these practices from being more widespread, and to what listeners can do to support a more circular Florida. Along the way, the guests speak candidly about the realities of thin margins, volatile markets, red tide, local ordinances, and the long arc of agriculture's shift from generalist to specialist, and back again.  Voices of Florida Farmers: Building a Circular Bioeconomy was made possible through a grant from VoLo Foundation. The full report is a substantive look at the 44,400 farms and ranches that make up Florida agriculture, the pressures they face from rapid development and a changing climate, and the policy, research, and market support that would allow them to go further in cycling nutrients, rebuilding soil, sequestering carbon, and strengthening local economies. The link is in the show notes. Florida agriculture deserves your attention, and this report is a great place to start.  Links: Read the Report: bit.ly/Florida-Voices-Circular-Bioeconomy    Florida Smart Agriculture's work:  www.solutionsfromtheland.org/flcsa   Connect with Beaver Yoder: https://www.thisfarmcares.org/steveyoder Connect with Lanette Sobel: https://fertileearth.net/ Connect with Timothy Solano: https://www.instagram.com/clamcaptain/ Learn more about "Fresh from Florida": https://followfreshfromflorida.com/      

This is part three of a ten-part podcast series documenting the European Industrial Hemp Association's 23rd Annual Conference in Poznan, Poland, at the Institute of Fiber Plants and Medicinal Medicine, June 10-12. Estelle Delangle, director of the Hemp European Hub in Troyes, France, frames the hemp challenge differently than most: The material isn't the problem, the world is. "The world is not ready for hemp. Today, when you use hemp in textile, for example, you have to make it look like something else. You have to make it look like cotton. You have to make it look like wool. You have to make it look like linen or flax," she said. Delangle has spent six years building the Hemp European Hub — a cooperative company that coordinates complex, cross-sector projects across Europe and beyond. The Hub isn't a traditional industry cluster or a government agency. It's a working laboratory for what Delangle calls "cooperative bioeconomy applied to hemp." The European hemp model, she explains, rests on three pillars: farmers who built their own markets and machines; price stability that makes the sector resilient; and whole-plant utilization — fiber for textiles, grain for food, hurd for bedding and leaves for extraction. No waste. "We are trying to do at the hub is to act stone by stone on those socio-technical obstacles," Delangle said, describing her approach to regulatory change, consumer perception and cross-sector cooperation. "Time is key. You don't change the world overnight." The Hub hosts the World Hemp Forum every two years in Troyes, drawing 300 participants from around the world. The next edition is November 24–26, 2026. Learn More Hemp European Hub (Pôle Européen du Chanvre) https://www.pole-europeen-chanvre.eu World Hemp Forum 2026 https://www.pole-europeen-chanvre.eu/world-hemp-forum La Chanvrière — Hemp Cooperative https://www.lachanvriere.com InterChanvre — French Hemp Industry Organization https://www.interchanvre.org Institute of Natural Fibers and Medicinal Plants (IWNIRZ) iwnirz.pl European Industrial Hemp Association (EIHA) eiha.org/ EIHA Conference eiha-conference.org/ Thanks to Our Sponsors Condor Seed condorseed.com HEMI — The Hemp Education and Marketing Initiative thegoodnessofhemp.org Bish Enterprises — FiberCut Hemp Harvesting bishenterprise.com/fibercut 1937 International 1937international.com

Unlocking India's Biotechnology & Life Sciences Potential | Dr. Pallu Reddanna | In the Line of Fire with SarajReal Leaders. Real Talks. Real Insights. Real Impact.In this powerful conversation, Dr. Pallu Reddanna shares his remarkable journey from a small village in Andhra Pradesh to becoming one of India's most respected biotechnology leaders, institution builders, and innovation advocates.As Executive President of FABA and Founder Director of NIAB, Dr. Pallu offers deep insights into the future of biotechnology, life sciences, healthcare innovation, academia-industry collaboration, venture capital, and the untapped research potential India holds.The big question is:Can industry, academia, entrepreneurs, and venture capital come together to unlock this opportunity?In this episode, we explore:• The future of biotechnology and life sciences• Why India must invest in research and innovation• Academia-industry collaboration• Venture capital in biotech and healthcare• Building startups and innovation ecosystems• Leadership lessons from four decades of science and institution building• Advice for future leaders, researchers, and entrepreneursThis conversation is a must-watch for CEOs, CXOs, founders, venture capitalists, researchers, scientists, policymakers, and emerging leaders.Join the Show. Share Your Leadership Legacy. Inspire. Empower. Transform.

Today, we're exploring the growing momentum behind Ireland's bioeconomy – a space where agriculture, energy, and sustainability intersect to create new opportunities.From biomethane and renewable fuels to circular farming systems and new revenue streams, this is about rethinking how we use resources – and how we build a more sustainable future.In this episode, we hear from leaders across finance, farming, and industry, recorded at the All-Island Bioeconomy Summit which took place at Johnstown House in County Meath recently.Visit www.thinkbusiness.ie for more news and supports for start-ups and SMEs in Ireland. If you want to start and grow a business, ThinkBusiness.

BRAIN Biotech AG 6M FY 2025/26: Key TakeawaysPresented by Michael Schneiders, CFOIn this latest financial results presentation on seat11a, Michael Schneiders of BRAIN Biotech AG presents the company's 6M FY 2025/26 financial results and provides an update on operational developments across its enzyme business and BioIncubator activities.Industrial Biotechnology Platform with Two-Pillar StructureBRAIN Biotech continues to position itself as a provider of industrial biotechnology solutions, combining enzyme technologies, microbial systems, and biotechnology-driven industrial applications across food, life sciences, chemicals, health, and sustainability-related markets.The company operates through its two-pillar structure consisting of the operational enzyme business BRAINBiocatalysts and the innovation-focused BRAINBioIncubator platform.Sequential Growth in the Enzyme BusinessDuring the first six months of FY 2025/26, the company reported sequential growth in the enzyme business during Q2 compared with Q1, while the enzyme-related CRO business remained solid.BRAIN Biotech also successfully commissioned its new Netherlands production facility on time and within budget, with management expecting operational synergies and efficiency improvements from the site going forward.The continued development of the enzyme business remains strategically important for the company as it seeks to expand its position in industrial biotechnology and higher-value biocatalyst applications.BioIncubator Advances Scientific and Strategic InitiativesWithin the BioIncubator segment, the company continued to advance several strategic and scientific initiatives.BRAIN Biotech received a European patent for its genome editing nuclease BMC®, which management highlighted as opening additional licensing opportunities for the CRO business and biotechnology applications.In addition, portfolio company Akribion Therapeutics published research in Nature magazine related to RNA-triggered cell killing using CRISPR-Cas12a2 technology, underlining ongoing scientific progress within the BioIncubator ecosystem.Improved EBITDA and Ongoing Cost DisciplineFinancially, revenues reached €23.4 million during the first six months, while adjusted EBITDA improved significantly to approximately break-even.Management highlighted milestone income, operational integration measures, and ongoing cost control as important factors during the reporting period.The company continues to emphasize operational discipline, efficiency improvements, and careful capital allocation as part of its broader strategy to strengthen financial resilience while advancing biotechnology innovation.Guidance and Mid-Term Targets ConfirmedBRAIN Biotech also confirmed its FY 2025/26 guidance and maintained its broader mid-term targets presented during the Capital Markets Day in December 2024.These targets include long-term growth ambitions for the enzyme business and continued expansion across biotechnology and bioeconomy applications.Investor PerspectiveFor investors, BRAIN Biotech remains positioned around several structural growth themes, including industrial biotechnology, sustainable production processes, enzyme innovation, genome editing technologies, and bioeconomy..Read more: https://seat11a.com/company/brain-biotech-ag-financial-results-h1-2025-26/ ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Host Claire Concannon is in the field this week, so Liz Garton is with us to talk about her visit to the Bioeconomy Science Institute.

The European Union aims to achieve carbon neutrality by 2050: that means the volume of CO2 produced by human activities is equal to the volume that can be absorbed by the natural environment — mainly soils, forests and oceans. Currently, we produce four times more than the volume that can be absorbed by these natural carbon sinks. So, the race is on to decarbonise our economy and find alternatives to fossil-based products. This is what underpins the bioeconomy strategy adopted by the European Commission at the end of November last year. For this 70th episode, the Food for Europe podcast takes you to meet entrepreneurs who are repurposing materials previously considered waste by farmers and foresters. Lewin Fricke, from the German start-up TriqBriq, introduces us to his ingenious and sustainable system of interlocking timber bricks that is revolutionising the construction sector. Götz Graf Bülow, regional manager at ForstBW, the public forestry company of Baden-Württemberg, explains how new sustainable supply chains have positive benefits for foresters and forest management. In Hungary, Andrea Veres, honorary associate professor at the Hungarian University of Life Sciences and Agriculture, tells us about her start-up Agrologika, which recycles sheep's wool to make fertiliser pellets. Finally, Michael Losch, Bioeconomy Coordinator at the European Commission's Directorate-General for Agriculture and Rural Development, discusses the ins and outs of the European bioeconomy strategy.

Protein engineering has traditionally been slow, expensive, and stuck in trial-and-error mode—but AI is changing everything. In this episode, we sit down with Elise De Reus, co-founder of Cradle Bio, to explore how generative AI is revolutionizing the way scientists design proteins for medicines, enzymes, and sustainable materials. Elise shares her journey from studying fungi and building high-throughput strain engineering systems at companies like Zymergen and Perfect Day, to creating an AI-powered platform that helps R&D teams generate better protein variants in less time and at lower cost. We discuss the massive design space of proteins, the role of machine learning in navigating that complexity, how Cradle balances computational predictions with biological reality, and what it will take for the bioeconomy to reach its trillion-dollar potential. Whether you're in pharma, industrial biotech, or just curious about the future of biology as a design problem, this conversation offers a fascinating look at how AI is becoming an essential tool for engineering the building blocks of life.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Chapters:(00:00:00) - The AI Revolution Meets Biology(00:01:00) - Why Erum Switched from ChatGPT to Claude (And What It Means for AI)(00:03:00) - Lab-Grown Meat Just Got Real: The Breakthrough That Changes Everything(00:06:00) - The Roadmap to a Trillion-Dollar Bioeconomy: Inside the AB4S Report(00:08:00) - Proteins 101: The Molecular Machines Running Your Life(00:10:00) - From Studying Fungi to Building AI Tools: Elise De Reus's Origin Story(00:12:00) - Inside Cradle Bio: The AI Studio Transforming How Scientists Design Proteins(00:15:00) - The "Short, Fat Data" Problem: Why Protein Engineering Needs Different AI(00:18:00) - Finding Needles in Infinite Haystacks: How Generative AI Navigates Protein Space(00:23:00) - When AI Is Confident But Wrong: Balancing Predictions with Biological Reality(00:27:00) - Speed vs. Caution: Why Pharma and Industrial Biotech Innovate Differently(00:30:00) - The $500 Billion Question: What's Really Blocking the Bioeconomy?(00:35:00) - Success Stories: How AI Unstuck Projects That Were Going Nowhere(00:38:00) - Sequence vs. Structure: Which AI Models Win at Protein Design?(00:41:00) - The Future Is Here: Better Data, Faster DNA Assembly, and Smarter Tools(00:43:00) - Quick Fire: Elise's Hot Takes on Biotech's Biggest Questions(00:47:00) - Biology as a Design Problem: Why This Changes EverythingLinks and Resources:CradleTurning lab-grown yeast into edible scaffoldingSynBioBeta Pass - Discount code: Grow Everything 166. The Great Reformulation: Joshua Lachter Rethinks How We Make Everything at ScaleTopics Covered:protein design, protein engineering, biotech, lab automation, biomanufacturing. synthetic biology, AI drug discovery, directed evolution, biologics, computational biology, enzyme optimizationHave a question or comment? Message us here:Text or Call (804) 505-5553⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠Music by: Nihilore Production by: Amplafy Media

A desire and passion for caring for the earth, soil, and the natural environment can start at a young age.Fatema Mohajir and her family are from the Bamyan province in central Afghanistan. As a child, Fatema's family lived in Iran, where her father worked at a large-scale vegetable farm. Fatema's father and older brother inspired her interest in soil science and farming.Fatema studied at Kabul University and graduated in 2020. As a part of her studies, Fatema participated in a year-long Permaculture Program led by Rosemary Marrow from Australia. After graduating, Fatema received a scholarship to study in Uzbekistan, where she focused on bioeconomy and irrigation.Fatema moved to the United States in 2023 and has been working at the Farm at Willow Run in Harrisonburg for the past two seasons. Fatema shares about her interest in organic farming and her overall aim to be a role model for others in caring for the earth, soil, and the bioeconomy.To learn about Virginia Mennonite Retirement Community's farm-to-table initiative and the Farm at Willow Run, please visit https://www.vmrc.org/the-farm. You can listen to Rosemary Morrow's Journey to Permaculture on The Permaculture Podcast.We can all be 4 The Soil, for the future! Here is how with four principles:1) Keep the soil covered -- with living plants and residue. Cover crops are our friends and allies; avoid leaving soil bare.2) Minimize soil disturbance -- Practice no-till or gentle tillage as much as possible in your field or garden.3) Maximize living roots -- for the longest time to improve biodiversity, soil structure, and life in the soil.4) Energize with diversity -- aboveground and belowground with high-quality food for soil and plants, and integration of livestock on cropland. If you are interested in art and framing the 4 The Soil posters for your office or home, the 16” by 20” posters are available for purchase and printing as single posters or a set of five posters.If you have questions about soil and water conservation practices, natural resource concerns, and soil health principles and practices to restore the life in your soil, call or visit a USDA Service Center, a Virginia Soil and Water Conservation District office, or your local Virginia Cooperative Extension office.  4 the Soil: A Conversation is made possible with funding support from the National Fish and Wildlife Foundation and The Agua Fund. Other partners include the USDA Natural Resources Conservation Service; Virginia Cooperative Extension; Virginia State University; Virginia Department of Conservation and Recreation; and partners of the Virginia Soil Health Coalition.Disclaimer: Views expressed on this podcast are those of each individual guest.To download a copy of this, or any other show, visit the website 4thesoil.org. Music used during today's program is courtesy of the Flip Charts. All rights reserved. 4 the Soil: A Conversation is produced by On the Farm Radio in collaboration with Virginia Tech. The host and co-hosts are Jeff Ishee, Mary Sketch Bryant, and Eric Bendfeldt.

Show Notes for Computer AmericaStory 1: Real-world helper exoskeletons come closer to reality with AI trainingSource: TechXplore.comLink: https://techxplore.com/news/2025-11-real-world-helper-exoskeletons-closer.htmlResearch Paper: https://www.science.org/doi/10.1126/scirobotics.ads8652Story 2: New Augmented Reality Tech Can Turn Any Surface into KeyboardSource: University of Texas at DallasLink: https://news.utdallas.edu/science-technology/augmented-reality-tech-keyboard-2025/Story 3: Supercomputer Creates One of the Most Realistic Virtual Brains Ever SeenSource: ScienceAlert.comLink: https://www.sciencealert.com/supercomputer-creates-one-of-the-most-realistic-virtual-brains-ever-seenVideo 1: https://www.facebook.com/watch/?v=1531823138015033Video 2: https://www.youtube.com/watch?v=w5Xcx0dDwGQStory 4: Scientists Discover a Way to 'Recharge' Aging Human CellsSource: ScienceAlert.comLink: https://www.sciencealert.com/scientists-discover-a-way-to-recharge-aging-human-cellsResearch Paper: https://www.pnas.org/doi/10.1073/pnas.2505237122Video: https://www.youtube.com/watch?v=NHbSqcemBW8Honorable MentionsStory: CES product announcement: world's first sonic toothbrush equipped with SmartNose, an integrated connected sensor designed to analyze breath biomarkers in real timeSource: US-based company Autobrush CES announcement todayLink: https://tryautobrush.com/Story: AI trained on bacterial genomes produces never-before-seen proteinsSource: ArsTechnica.comLink: https://arstechnica.com/science/2025/11/generative-ai-meets-the-genome/Research Paper: https://www.nature.com/articles/s41586-025-09749-7Story: Department of Energy, PNNL Partner to Power the Nation's BioeconomySource: Pacific Northwest National LaboratoryLink: https://www.pnnl.gov/news-media/department-energy-pnnl-partner-power-nations-bioeconomyStory: Astro Mechanica teams with UK SME Helix to build hybrid-electric engines for the next generation of supersonic aircraftSource: Aerospace Global NewsLink: https://aerospaceglobalnews.com/news/astro-mechanica-helix-supersonic-engines-electric-motors/

Host Dr Hilary Ireland speaks with Dr Bevan Weir about the vital role Aotearoa New Zealand's nationally significant collections and databases play in protecting biodiversity and strengthening biosecurity. Bevan shares stories that highlight why taxonomy matters — from identifying the pathogen behind kauri dieback and protecting rare underground fungi, to preventing toxic new weeds, safeguarding avocado exports and responding to invasive pests. The conversation explores how centuries-old taxonomic science, combined with modern tools like DNA sequencing, computer vision and data analytics, enables accurate species identification and informed decision-making. Together, these approaches help manage biosecurity risks, support conservation and make these vital national resources accessible to researchers and the wider public. To view our full catalogue of podcasts including extra links on some podcasts please go to our Scigest pages: www.plantandfood.com/scigest.

From today until the 4th of December, a conference will be held in Queenstown that will look into pest management and how best to protect native species. The event not only brings experts in the sector from Aotearoa, but will also involve Australian experts as well. Tuesday Wire Host Sara spoke to Dr Sze-Wing Yiu, a Wildlife Ecologist at the Bioeconomy Science Institute, about this week's conference, and what to expect.

From agbioscience innovation to defense, pharma, food and nutrition, and beyond – the bioeconomy is broad; and the intersection of innovation, research and policy generates a lot of questions when it comes to how we grow and scale to be a global leader right here in the United States. This week, we are joined by Sarah Glaven, Visiting Fellow at Princeton University's Andlinger Center and a former biotechnologist representing The White House, The Pentagon and The Naval Research Laboratory. We get into:  Sarah's professional story, from being an outdoors kid to leading critical bioinnovation work on a national scale How she defines the bioeconomy and what she believes is its importance to the US' future Biggest headwinds we are facing when it comes to the growth and scale of the bioeconomy How her past experiences have shaped her perspective on the critical alignment needed among policy, innovation and research to advance the bioeconomy in the US (and the grade she'd give us on that alignment today) Indiana's position in the bioeconomy and how reshoring biomanufacturing supply chains can reduce disruption and increase competitiveness in the US Creating a skilled workforce to grow the bioeconomy and examples of upskilling and developing talent that have her most impressed What has Sarah most excited about the US' bioinnovation future 

In this episode, Erum and Karl unpack six major reports that define the current state of synthetic biology and the bioeconomy. From investment trends to national security concerns, from manufacturing failures to trillion-dollar opportunities, these reports paint a complex picture of an industry at a critical turning point.Episode Links:Ig Nobel PrizeSynBioBeta 2025 Investment ReportWorld Economic Forum's Report with CapgeminiAdvanced Biotech for Sustainability Coalition Report BIO and Kearney's Bioeconomy Impact Modelling Report National Security Commission on Emerging Biotechnologies Report  First Bight Ventures to Buy a Manufacturing Graveyard Report Link 150th episode Alexander Titus epAngela Belcher epGenspaceBreak into BiotechNSF and NVIDIA PartnershipTopics Covered: natural resources, feedstocks, bioprocessings, biomanufacturing, consumer products and goods, biotech, industry reports   

In this episode of YourForest, Matthew Kristoff and guest Shauna Matcovich explore the world of forest finance and the critical role of private capital in funding sustainable forestry. Shauna, a forester and founding director of The ForestLink, discusses the need to link the intrinsic values of a forest - such as its biodiversity and ecosystem health - to a monetary economy in order to drive conservation. The conversation highlights how private investment can be a powerful lever for change and a way to create a more resilient and sustainable forest industry.

Several hundred state leaders in agriculture and manufacturing gathered in Kearney today/Thursday to discuss how to develop Nebraska's economy. Gov. Jim Pillen touted the potential for Nebraska to grow its bioeconomy through investments in ethanol, sustainable aviation fuel and plastic products made from corn. Thursday morning, Husker football head coach Matt Rhule addressed the summit with a message about dreaming big. The governor said he's dreaming big too.

There is apparently an ever increasing demand for willow baskets, panniers, handbags, bird feeders, and obelisks for climbing plants. And only a very small number of people with the skills to make them. Sarah Jenkinson runs her own workshops in Galway.

In this episode, we're diving into the future of biomanufacturing with Dr. Doug Friedman, CEO of BioMADE. From bio-based plastics to revolutionary food tech, biomanufacturing is transforming industries, creating jobs, and keeping the U.S. competitive. Can biology replace fossil fuels? Can biotech revolutionize global supply chains? Let's find out!Stay tuned as we explore the science, strategy, and economic impact of the bioeconomy.Also, don't forget to subscribe to IE+ for premium insights and exclusive content!

First, we talk to The Indian Express' Asad Rehman who discusses the concerns of the proposed changes in the Waqf Bill ahead of a parliamentary approval.Next, The Indian Express' Amitabh Sinha talks about India's bioeconomy sector and the potential it holds for greater opportunities. (12:51)Lastly, we discuss the Member Private Bills tabled in Jammu and Kashmir's Assembly demanding the restoration of the region's statehood (25:24)Hosted by Ichha SharmaProduced and written by Niharika Nanda and Ichha SharmaEdited and mixed by Sureah Pawar

Our guests in The Sustainable Hour no. 541 are Elizabeth Corbett from AE global, and Brendan Condon from Australian Ecosystems and Regen Nurseries.

The way we produce and consume protein is changing. With the global demand for meat at an all-time high and set to double by 2050, the need for sustainable alternatives has never been more urgent. Alternative proteins—whether plant-based, cultivated, or fermentation-derived—offer a way to feed more people with fewer resources, reduce environmental impact, and build a more resilient food system.In this episode, we explore the future of food with Devika Suresh, a champion for alternative proteins in India. Passionate about the intersection of technology and sustainability, Devika has been instrumental in advancing smart protein education, research, and innovation. She works to build pathways for young Indians to shape this growing industry and drive meaningful change in how we think about food.What to Expect in This Episode:The Basics of Smart Protein: What exactly is alternative or smart protein, and why should anyone care? Devika breaks down the essentials and explains the impact on food security, climate change, and planetary health.India's Path to Net Zero: Can India realistically achieve its 2047 Net Zero target, and how have policies like BioE3 contributed to the positive momentum?The Bioeconomy Movement: With terms like "Bioeconomy" gaining traction globally, Devika explains what this means for India and the world.Consumer Perceptions: We tackle common misconceptions around alternative proteins and explore strategies to shift the narrative from niche to mainstream.Cultural Nuances and Market Dynamics: Why is India strategically positioned to lead in this sector? Devika discusses cultural factors, market drivers, and setbacks, and how to avoid another "organic" déjà vu.Regulatory Landscape: How has the FSSAI's framework supported this industry, and what lessons can be drawn from other countries?The Role of Big Brands: With major corporations entering the space, why is mass acceptance still a challenge, and when can we expect a shift in consumer attitudes towards taste, price, and process?Future Predictions: What innovations and products could be game changers in the next 10-20 years? We also explore Devika's vision for the future—what food we want on our plates by 2050, and how India can play a pivotal role in feeding a growing global population sustainably.Tune in to hear her insights, predictions, and her passion for reshaping the future of food. Whether you're curious about sustainable eating or looking to understand the business of alternative proteins, this episode offers a compelling look at the intersection of food, technology, and climate action.

Doug Friedman joins the podcast to talk about one of the toughest challenges in biotech—how to survive long enough to actually make an impact. As the head of BioMADE, he's on a mission to build a bioindustrial manufacturing ecosystem that doesn't just rely on wishful thinking and a single grant check. He explains why most biotech startups get only "one shot on goal" (spoiler: they miss, they're done) and how we can fix that. Think of it like debugging a bad DNA sequence—you need iteration, not instant perfection. Doug also discusses how government funding is shaping the future of biomanufacturing, why biology today is where semiconductors were in the ‘80s, and why scaling biology might just need its own version of Moore's Law. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at www.messaginglab.com/groweverything  Chapters: 00:00:00 – Fail Fast or Fail Forever – Why biotech startups need more than one shot on goal 00:00:27 – AI Shake-Up – DeepSeek changes the game (and the stock market) overnight 00:01:01 – China vs. AI – What a hedge fund, government crackdowns, and new algorithms have in common 00:02:19 – Power Hungry AI – Why data centers might outgrow the energy grid before we're ready 00:03:36 – DeepSeek's Disruption – What it means for AI, efficiency, and the future of computing 00:04:13 – Innovation Under Pressure – How limitations create the best breakthroughs 00:05:46 – Mind Reading? – The wild world of telepathy research and what it means for biotech 00:07:45 – Quantum Strangeness – Exploring dimensions beyond what we can see 00:09:17 – Longevity Hacks – The Brian Johnson experiment: biohacking or billion-dollar placebo? 00:12:48 – Biomanufacturing is Booming – Why the future of production is biological 00:28:35 – PFAS Panic – 3M halts production, and microelectronics scrambles for solutions 00:30:53 – BioMADE's Master Plan – How industry collaboration is making biomanufacturing real 00:36:56 – Government Meets Biotech – Bridging public and private sectors for impact 00:38:44 – The Bioeconomy is Here – What it means for industries beyond biotech 0:42:29 – Talk to Your Legislators – How to get policymakers to care about biotech 00:46:08 – The Hardest Part of Biomanufacturing – What innovators need to overcome 00:50:42 – Biomanufacturing's Future – The biggest opportunities waiting to be unlocked 00:52:46 – Final Thoughts – Wrapping up lessons from the frontier of biotech Links and Resources: BioMADE Homeworld Collective (Apply today!) The Climate Biotech Podcast DeepSeek Wipes $1 Trillion from Tech Share Prices The Telepathy Tapes Don't Die, The Man Who Wants to Live Forever Rapamycin General Probiotics Antheia Schmidt Sciences Liberation Labs Topics Covered:  biomanufacturing, collaboration, public private partnerships, distributed biomanufacturing, longevity biotech, telepathy, tech  Have a question or comment? Message us here: Text or Call (804) 505-5553  Instagram  / Twitter / LinkedIn / Youtube / Grow Everything Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

In this episode we're diving deep into the fascinating world of carbon recycling with a trailblazer who's reshaping how we think about waste and sustainability. Our guest is Dr. Jennifer Holmgren, CEO of LanzaTech—a company on a mission to transform our biggest environmental challenge into an economic opportunity. LanzaTech is pioneering a process that takes industrial emissions—the kind of harmful gases that typically contribute to climate change—and recycles them into valuable products like fuels, fabrics, and everyday consumer goods. The concept might sound like science fiction, but it's already science fact. LanzaTech's technology captures carbon emissions from sources like steel mills, refineries, and even municipal solid waste, then feeds those emissions to specially engineered microbes. These microbes act like tiny factories, converting carbon pollution into useful materials. Imagine jet fuel made from industrial waste or yoga pants created from captured carbon—it's not just possible; it's happening. In fact, at the very end of 2024, LanzaTech received a holiday gift from the federal government: a $200 million award from the Dept. of Energy. In this episode, Jennifer and I discuss the path LanzaTech took, including raising $400 million and taking 13 years prior to commercializing its first product. We also touch on her personal journey from her birth in Colombia to her taking the helm at LanzaTech. As you'll hear, this isn't just about reducing emissions; it's about completely rethinking the role of waste in our economy. LanzaTech's vision is one where carbon is no longer a liability but an asset—a resource that can be reused and recycled, over and over again. It's a powerful example of how businesses can align profitability with purpose, and it's precisely the kind of story that inspires hope in these challenging times. So, whether you're an entrepreneur, an environmentalist, or just someone curious about the future of our planet, this is a conversation you won't want to miss.  Discussed in this episode Jennifer recommends reading Quiet by Susan Cain. LanzaTech awarded up to $200 million in federal cash from the DOE LanzaTech is backed by Khosla Ventures. More about Jennifer Holmgren, PhD Dr. Jennifer Holmgren is CEO of LanzaTech. Under her guidance, LanzaTech is developing a variety of platform chemicals and fuels, including the world's first alternative jet fuel derived from industrial waste gases. Given her integral role in the development of this alternative jet fuel, she is also a Director and the Chair of the LanzaJet Board of Directors.  Prior to LanzaTech, Jennifer was VP and General Manager of the Renewable Energy and Chemicals business unit at UOP LLC, a Honeywell Company. While at UOP, she was a key driver of UOP's leadership in low carbon aviation biofuels, and under her management, UOP technology became instrumental in producing nearly all the initial fuels used by commercial airlines and the military for testing and certification of alternative aviation fuel. Jennifer is the author or co-author of 50 U.S. patents and more than 30 scientific publications, and is a member of the National Academy of Engineering. In 2003, she was the first woman awarded the Malcolm E. Pruitt Award from the Council for Chemical Research (CCR). In 2010, she was the recipient of the Leadership Award from the Civil Aviation Alternative Fuels Initiative (CAAFI). In 2015, Jennifer and her team at LanzaTech were awarded the U.S. Environmental Protection Agency Presidential Green Chemistry Award, and she was awarded the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology. Jennifer was named as #1 of the 100 most influential leaders in the Bioeconomy in 2017 and received the Global Bioenergy Leadership Award in 2018, and the 2020 William C. Holmberg Award for Lifetime Achievement in the Advanced Bioeconomy. In 2021, she received the Edison Achievement Award and the Prix Voltaire Award. In 2022, she was included in ICIS's Top 40 Power Players ranking. Jennifer also has an honorary doctorate from Delft University of Technology. Jennifer is on the Governing Council for the Bio Energy Research Institute in India. The institute was set up by the DBT (Department of Biotechnology, Indian Government) and IOC (Indian Oil Corporation).  She also sits on the Advisory Council for the Andlinger Center for Energy and the Environment at Princeton University, the National Academies' Board on Energy and Environmental Systems (BEES), the External Advisory Committee for the Advanced Energy Technologies Directorate (AET) at Argonne National Laboratory, the Advisory Council for the Pacific Northwest National Laboratory (PNNL), the Halliburton Labs Advisory Board, the Universiti Teknologi PETRONAS International Advisory Council, and the Founder Advisory for The Engine, a venture capital fund built by MIT that invests in early-stage science and engineering companies.  Jennifer holds a B.Sc. degree from Harvey Mudd College, a Ph.D. from the University of Illinois at Urbana-Champaign and an MBA from the University of Chicago.

This CEO Is Using Biology To Make The World Better – Dr. Jennifer Holmgren, CEO, LanzaTech $LNZA Name: Dr. Jennifer Holmgren Title: Chair and CEO of LanzaTech Global, Inc. Ticker: LNZA Website: https://lanzatech.com/ Bio: Dr. Jennifer Holmgren is CEO of LanzaTech. Under her guidance, LanzaTech is developing a variety of platform chemicals and fuels, including the world's first alternative jet fuel derived from industrial waste gases. Given her integral role in the development of this alternative jet fuel, she is also a Director and the Chair of the LanzaJet Board of Directors. Prior to LanzaTech, Jennifer was VP and General Manager of the Renewable Energy and Chemicals business unit at UOP LLC, a Honeywell Company. While at UOP, she was a key driver of UOP's leadership in low carbon aviation biofuels, and under her management, UOP technology became instrumental in producing nearly all the initial fuels used by commercial airlines and the military for testing and certification of alternative aviation fuel. Jennifer is the author or co-author of 50 U.S. patents and more than 30 scientific publications, and is a member of the National Academy of Engineering. In 2003, she was the first woman awarded the Malcolm E. Pruitt Award from the Council for Chemical Research (CCR). In 2010, she was the recipient of the Leadership Award from the Civil Aviation Alternative Fuels Initiative (CAAFI). In 2015, Jennifer and her team at LanzaTech were awarded the U.S. Environmental Protection Agency Presidential Green Chemistry Award, and she was awarded the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology. Jennifer was named as #1 of the 100 most influential leaders in the Bioeconomy in 2017 and received the Global Bioenergy Leadership Award in 2018, and the 2020 William C. Holmberg Award for Lifetime Achievement in the Advanced Bioeconomy. In 2021, she received the Edison Achievement Award and the Prix Voltaire Award. In 2022, she was included in ICIS's Top 40 Power Players ranking. Jennifer also has an honorary doctorate from Delft University of Technology. Jennifer is on the Governing Council for the Bio Energy Research Institute in India. The institute was set up by the DBT (Department of Biotechnology, Indian Government) and IOC (Indian Oil Corporation). She also sits on the Advisory Council for the Andlinger Center for Energy and the Environment at Princeton University, the National Academies' Board on Energy and Environmental Systems (BEES), the External Advisory Committee for the Advanced Energy Technologies Directorate (AET) at Argonne National Laboratory, the Advisory Council for the Pacific Northwest National Laboratory (PNNL), the Halliburton Labs Advisory Board, the Universiti Teknologi PETRONAS International Advisory Council, and the Founder Advisory for The Engine, a venture capital fund built by MIT that invests in early-stage science and engineering companies. Jennifer holds a B.Sc. degree from Harvey Mudd College, a Ph.D. from the University of Illinois at Urbana-Champaign and an MBA from the University of Chicago.

Karl and Erum give us a peek into their outlook for 2025, discussing biotech trends, the rise of decentralized science, and the convergence of AI with biology. They talk about the thawing of the "biotech winter," the potential risks of a new bird flu pandemic, and exciting innovations in quantum biology and drug discovery. Their conversation also touches on how waste can become a resource in biomanufacturing, the future of microbiome engineering, and the growing visibility of biotech in mainstream media. Tune in to hear Karl and Erum set the stage for an exciting year ahead in the world of biotech and beyond​. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠www.messaginglab.com/groweverything⁠⁠ Chapters: 00:00:00 – The Mushroom That Might Save Us All 00:00:15 – A Slightly Nasal New Year Kickoff 00:01:30 – Bird Flu: The Pandemic Alarm We're Ignoring 00:04:43 – Decentralized Science: Funding the Future with Tokens 00:08:16 – AI, Quantum Biology, and Drug Discovery Breakthroughs 00:11:36 – Turning Trash into Treasure: Biomanufacturing's Next Frontier 00:14:12 – Microbiomes: Tiny Giants in Biotech's Future 00:16:14 – Biotech Goes Mainstream: Ads, Cartoons, and Pop Culture 00:19:54 – 2025 Awaits: A Year of Big Ideas and Bold Moves Episode Links: Spore Token   ARPA-H Vitalia - Join today!  Vitalia Summer School Program - Enroll today! Cemvita  Polybion Head & Shoulders x NFL scalp microbiome commercial Nike Stairs commercial American Dad gene editing episode Common Side Effects on Adult Swim Topics Covered:  2025 outlook, decentralized science, quantum biology, longevity biotech, waste to value, waste as a resource, biomaterials, bioeducation, microbiome Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠Instagram⁠⁠  / ⁠⁠Twitter⁠⁠ / ⁠⁠LinkedIn⁠⁠ / ⁠⁠Youtube⁠⁠ / ⁠⁠Grow Everything⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Kevin Flyangolts joins Erum and Karl to talk about the evolving landscape of biosecurity. They discuss the rapid advancements in biotechnology, the growing accessibility of synthetic DNA, and the need for robust screening systems to ensure safety in the bioeconomy. Kevin shares knowledge from his software background, explaining how tools like those at Aclid Bio are bridging gaps in security, protecting against potential misuse, and setting the stage for future innovations in biotech. With reflections on government initiatives, industry collaboration, and the complexities of ethical biosecurity practices, this conversation showcases the urgent issues and exciting possibilities in the intersection of biology and technology. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at www.messaginglab.com/groweverything Chapters: 00:00:00 - Opening with Unchecked DNA Risks 00:00:22 - Drones, Aliens, and the Unknown 00:01:45 - The Biotech Holiday Buzz 00:04:18 - Manufacturing the Future: A Revolution Begins 00:07:05 - DARPA's Wild Moonshot Ideas 00:09:47 - What Keeps Us Up at Night 00:11:55 - Meet Kevin: Biosecurity Pioneer 00:15:30 - The Software Revolution in Biotech 00:19:45 - Tackling Biosecurity Challenges with Innovation 00:24:58 - Regulations in a Rapidly Changing Field 00:28:59 - Red Teams and Hidden Vulnerabilities 00:39:04 - Building Biotech Trust and Collaboration 00:44:21 - A Vision for Safer Biotech 00:46:59 - Wrap-Up and What's Next in Biosecurity Episode Links: Aclid Bio Genspace ECHO NYC Biolabs@NYULangone Quorum Bio The Department of Defense under the Distributed Bioindustrial Manufacturing Program (DBIMP) made 34 awards worth over $60 million. Awardees include Cauldron and Checkerspot. Topics Covered:  biosecurity, DNA synthesis, BIOSECURE Act, computer science Have a question or comment? Message us here: Text or Call (804) 505-5553 Instagram  / Twitter / LinkedIn / Youtube / Grow Everything Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Irish organisations have been awarded more than €836 million in funding from the EU's Horizon Europe 2021 -2027 research and innovation programme. The current seven-year programme aims to support organisations to tackle global challenges, conduct groundbreaking multidisciplinary research and boost the EU's industrial competitiveness and growth. Ireland's overall national drawdown target is €1.5bn or 1.6% of Horizon Europe's €93.5bn budget from 2021-2027. To date, Irish organisations have been granted €836.4m which equates to 2.14% of the €39 billion awarded so far, showing that Ireland is tracking ahead of its target at just past the halfway point of the programme. Irish organisations awarded €836 million by EU Horizon Europe The €836 million secured by Irish organisations is distributed across 1,295 projects involving 487 individual Irish organisations and businesses. Almost half of those 487 organisations (47%) have been awarded more than a quarter of a million euros, while one in five have secured greater than €1 million. Successful applicants from Ireland are drawn from a range of sectors and include higher education institutions, research-performing organisations, public organisations and SMEs. 217 Irish SMEs have been awarded €233m under Horizon Europe and Ireland ranks at number four amongst the 27 EU member states for SME participation in projects. The top three biggest funding successes for Ireland under the Horizon Europe framework programme areas are: 1) the European Research Council's grants for academic researchers - €131m 2) the Digital, Industry & Space programme area - €122m 3) the Food, Bioeconomy, Natural Resources, Agriculture and Environment programme area - €121m The figures were announced today as more than 600 delegates including EU member state representatives, policymakers and industry leaders from the research and business community attend the Horizon Europe Impact Conference at the Convention Centre in Dublin. This in-person conference will highlight Ireland's success in Horizon 2020 and Horizon Europe by showcasing the benefits that participation from small and large enterprises, academic researchers and other stakeholders has produced. Speaking at the conference, Colm O'Reardon, Secretary General at the Department of Further and Higher Education, Research, Innovation and Science said, "This is a welcome opportunity to take stock at the halfway point of Horizon Europe, to reflect on our successes so far and look forward to Ireland leading and participating in impactful research and innovation projects with our international partners." Enterprise Ireland leads the Horizon Europe National Support Network which aims to promote and secure funding for Irish research projects. Opening the conference Micol Martinelli, National Director for Horizon Europe in Ireland, welcomed the European delegation to Dublin and commended the talent and calibre of innovation coming out of Ireland in recent years. "Ireland's overall success in the Horizon Europe programme, supported by Enterprise Ireland and nine other government agencies and departments, shines a spotlight on the innovation capability of Irish organisations which are competing and winning on a pan-European level. This EU funding is instrumental in providing critical support to enable researchers to further develop their innovations which will influence and strengthen EU policy for the good of future generations." "However, funding awards are not the only success story - the collaboration and building of partnerships and relationships with organisations in other countries is a key driver of impact for research and innovation overall. To unleash Ireland's full potential, we want to encourage and facilitate newcomers and to build on Irish participation for the remainder of the Horizon Europe programme and beyond." The Horizon Europe Impact Conference will cover the three pillars of Horizon Europe's focus including research excellence, researcher mobility a...

Karl and Erum are taking us deep into the intersection of biology, industry, and innovation with their guest, Jason Kakoyiannis. Jason is the founder of Bioscentric, advisor at Allonnia, and managing partner of Ferment! From starting his journey in the art world to leading the charge at Ferment, Jason shares how curiosity and the drive to solve complex problems led him to build a venture studio focused on market-driven biotech solutions. They discuss how biology can unlock sustainable answers to big challenges, like optimizing energy systems or creating eco-friendly alternatives in manufacturing. Along the way, Jason explains how his team finds the right problems to tackle and builds companies that merge creativity with real-world impact. It's a fascinating look at how biotech is shaping our future—one bold idea at a time! Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 The Start of Competitive Biology 00:00:14 Thanksgiving Tales and Biotech Beginnings 00:03:26 Weather Extremes Meet Biology 00:04:54 Plastic-Eating Bacteria: Nature's Unexpected Ally 00:10:49 Jason Kakoyiannis: From Art to Biotech Revolution 00:15:40 Inside the Ferment Fund: Building Future Biotech 00:31:22 A New Model: Revenue-Driven Biotech Companies 00:32:30 Venture Studio Secrets Revealed 00:33:45 Behind the Scenes with the Ferment Team 00:35:09 The Role of Entrepreneurs in Residence 00:36:12 Alchemica's Vision: Transforming Natural Gas Production 00:41:41 Biobased Solutions: Untapped Market Opportunities 00:46:00 Flexible Spending: A New Biotech Approach 00:48:15 Success Patterns in Building Biotech Startups 00:52:45 Ferment's Mission: Solving Real Problems 00:55:04 Reflections: Key Takeaways and Insights Topics Covered:  biotech funding, venture capital, venture studio, fermentation, startups, entrepreneurship, climate biotech. Episode Links: Jason Kakoyiannis on LinkedIn Ferment Co. - Request for Problems Neri Oxman on Lex Friedman's Podcast Scavengers Reign on Netflix Allonia  - Grow Everything episode with Nicole Richards Cultivarium -  Grow Everything episode with Nili Ostrov bitBiome — Grow Everything episode with Yuji Suzuki BiomEdit — Grow Everything episode with Aaron Schacht Cemvita — Grow Everything episode with Moji Karimi  Arcadia   Puna Bio Forge Biologics Ayana Bio⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

The future of biomanufacturing. In it we cover the emerging $4T bioeconomy, nature's ability to manufacture products, AI's acceleration of scientific discovery, China's quest for biological supremacy, and rethinking sustainability. Edward Shenderovich is CEO of Synonym, prior he was both an investor and entrepreneur, founding commercial real estate company Knotel where he raised over $400M and managed 200 locations across 4 continents. As an investor he founded Kite Ventures as well as Essential Capital, which include Delivery Hero and Fyber as their investments, both reaching IPO. Uniquely, Edward is also an accomplished Poet, having published multiple books in his native Russian. Sign up for new podcasts and our newsletter, and email me on danieldarling@focal.vcSee omnystudio.com/listener for privacy information.

In this Convo of Flanigan's Eco-Logic, Ted speaks with Maria Cho, CEO of Triplebar, a biotech firm using advanced technology to tackle the urgent issues of food and drug supply. She leads a team in a mission to heal and sustain people and the planet by removing a key bottleneck in the bioeconomy. This is being achieved with a proprietary screening platform to accelerate and innovate food and pharma product discovery.Based in East Bay, San Francisco, she shares with Ted that growing up, she was deeply intrigued by science and wanted to be a medical doctor. She began working as a medical assistant at a doctor's office, where she gained experience in the medical environment. While working as a medical assistant, she came to the decision that she did not want to pursue being a doctor. She realized her passion was more about the process of creating drugs rather than being a prescriber, and began thinking about how to get involved in creating products to help fight diseases worldwide.This discovery led to work and experience in various industries, including sales, research, biopharmaceuticals, and skincare. In her current role as CEO at TripleBar, she is leading a team focused on innovation and strategic growth to address some of the world's most challenging sustainability problems around food and healthcare by developing products that can meet current and future unmet needs for healthy nutrition and better disease treatment outcomes on a global scale. She and Ted delve into how they apply this in food and nutrition to bioactives, functional food proteins and cultured meat, and in pharma to better and novel biologics. Maria also discusses the broader implications of these technologies for the future of food and healthcare industries. She emphasizes the potential for bioengineering to not only solve current issues, but also to foresee and mitigate future challenges. Her vision includes fostering a more resilient and health-conscious global community through the application of science and technology.

Eben Bayer, founder of Ecovative, delves into the transformative power of mycelium technology and its potential to reshape industries from packaging to food production. He shares his journey from a small farm in Vermont to leading a company that pioneers sustainable materials, discussing how biology can be leveraged to create regenerative, profitable businesses. With a strong belief in the power of biology as technology, Eben explains how his innovations are not only environmentally friendly but also economically viable, offering a glimpse into the future of the bioeconomy. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 - Introduction: The Intersection of Biology and Technology 00:00:42 - Special Replay Episode Announcement 00:01:17 - The Synergy Between Biology and Technology: Transforming Industries 00:02:01 - Innovations in New York City: Industry Events Recap 00:03:41 - Sustainability Insights from Copenhagen: A Personal and Professional Perspective 00:07:45 - Eben Bayer's Vision: The Birth of Ecovative and Mycelium Technology 00:12:12 - Scaling Sustainable Solutions: Mycelium Production and Market Strategies 00:18:26 - Overcoming Challenges in Mycelium Technology and Global Expansion 00:19:31 - Licensing Mycelium Technology for Worldwide Impact 00:22:01 - Shifting Focus: From Packaging to Sustainable Food with My Forest Food 00:23:55 - Expanding Market Reach: Bringing Sustainable Products to More Consumers 00:24:23 - The Role of Natural Grocers and Co-ops in Promoting Sustainability 00:25:56 - Positive Consumer Feedback: The Power of Mycelium-Based Products 00:27:01 - Future Developments: Innovating for a Sustainable Tomorrow 00:31:07 - Off-Grid Living: A Personal Commitment to Sustainability 00:32:33 - Innovating Transportation: Electric Tractors and High-Speed Boats 00:34:11 - Biotech Inspirations: Must-Read Books and Influential Thinkers 00:35:00 - The Evolution of Plant-Based Meat: Navigating the Hype Cycle 00:36:44 - Reflections on Scaling Sustainable Innovation Topics Covered:  Biology As Technology, Sustainable Innovation, Mycelium Technology, Eco-Friendly Packaging, Bioeconomy, Regenerative Business, Plant Based Food, Off Grid Living, Biotech Innovation, Scaling Sustainability Episode Links: MyForestFoods.com Ecovative.com Eben Bayer on ⁠LinkedIn⁠⁠⁠⁠ Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Medi

Episode Description: we delve into the transformative power of synthetic biology in the construction industry with Ginger Dozier, the founder of Biomason. We explore how Biomason is leveraging microbes to create sustainable construction materials, such as bio-based bricks, that could revolutionize the built environment. The conversation touches on the challenges and opportunities of integrating biology into construction, the future of the bioeconomy, and the critical role of innovation in addressing global sustainability issues. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 - Introduction and the Origins of Inspiration 00:00:48 - Launching the Live Event 00:01:26 - Behind the Podcast: Purpose and Vision 00:02:34 - Acknowledgements and Industry Collaborations 00:05:31 - Meet Ginger Dozier: Innovator Behind Biomason 00:07:36 - Demystifying Synthetic Biology 00:10:09 - Understanding the Bioeconomy 00:13:30 - The Biomason Story: From Concept to Commercialization 00:21:52 - Opportunities and Challenges in the Bioeconomy 00:23:58 - The Microbiome's Role in Innovation 00:26:17 - Building with Biology: The Microbiome and the Built Environment 00:27:18 - The Biome Consortia: A New Vision for Collaboration 00:29:16 - Unlocking Microbial Potential for Innovation 00:31:56 - Navigating Bioeconomy Challenges and Innovations 00:35:46 - Audience Q&A: Imagining the Future of Microbial Technology 00:47:56 - Final Reflections and What's Next for Biomason Topics Covered: biotech, bioengineering, precision fermentation, biomineratization, microbiome, biocement, biobricks, biome consortia, bio futures, bioeconomy, climate, sustainability, mining Episode Links: Ginger Krieg Dosier on LinkedIn Biomason BIOME Consortia Biotech.xyz IndieBio Biolabs@NYU Langone MilliporeSigma Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

“We need positive visions of how all this technology gets deployed, because what we visualize is what we build.” –Jane Metcalfe In this episode of Deviate, Rolf and Jane talk about the pioneering work she did with Wired during the dawn of the “digital revolution” (3:00); how and why Jane’s professional focus shifted away from digital issues and into food and health issues in the ’00s (15:00); how science is trying to bring in diverse new data points and communication models to improve holistic health worldwide (28:30); how the health of the world’s humans is not separate from the health of the world’s animals, plants, and microorganisms, and how a bio-economy seeks to harness rather than extract the resources of nature (41:00); how regional and cultural differences affect how we perceive health, nutrition, and technology, and the importance of ethics in making scientific decisions (51:00). Jane Metcalfe (@janemetcalfe) is the co-founder of Wired Magazine, and the chair of the Human Immunome Project, a global non-profit working to decode the immune system in order to transform how we prevent, diagnose, and treat disease. Notable Links: Notes from a peripatetic salon across northern Thailand (Deviate episode) Hotwired (first commercial online magazine) HotBot (early web search engine) Louis Rossetto (writer, editor, and entrepreneur) Neuromancer, by William Gibson (science fiction novel) Snow Crash, by Neal Stephenson (science fiction novel) Cyberpunk (subgenre of science fiction) Electric Word (technology magazine) Digital Revolution (shift from mechanical to electronic technologies) Ethernet (computer networking technology) proto.life (newsletter covering the neobiological revolution) Neo.Life: 25 Visions for the Future of Our Species, by Jane Metcalfe (book) The Non-GMO Project (non-profit organization) David Eagleman (neuroscientist) Human genome (complete set of nucleic acid sequences for humans) Immunome (code set for proteins that constitute the immune system) Single-cell sequencing (context-driven technique for studying cells) Microbiome (community of microorganisms in a habitat) One Health (interdisciplinary approach to ecological health) Zoonotic disease (disease than can jump from non-humans to humans) Bioeconomy (use of biotechnology in the production of goods) CRISPR gene editing (technique to modify genomes of living organisms) Bioengineering (application of biology to create products) Interbeing (philosophical concept in Zen Buddhism) iGEM (worldwide synthetic biology competition) Gene drive (technology of genetic engineering) CRISPRcon (gene editing technology conference) Kevin Kelly (author and futurist) The Deviate theme music comes from the title track of Cedar Van Tassel's 2017 album Lumber. Note: We don't host a “comments” section, but we're happy to hear your questions and insights via email, at deviate@rolfpotts.com.

“We need positive visions of how all this technology gets deployed, because what we visualize is what we build.” –Jane Metcalfe In this episode of Deviate, Rolf and Jane talk about the pioneering work she did with Wired during the dawn of the “digital revolution” (3:00); how and why Jane’s professional focus shifted away from digital issues and into food and health issues in the ’00s (15:00); how science is trying to bring in diverse new data points and communication models to improve holistic health worldwide (28:30); how the health of the world’s humans is not separate from the health of the world’s animals, plants, and microorganisms, and how a bio-economy seeks to harness rather than extract the resources of nature (41:00); how regional and cultural differences affect how we perceive health, nutrition, and technology, and the importance of ethics in making scientific decisions (51:00). Jane Metcalfe (@janemetcalfe) is the co-founder of Wired Magazine, and the chair of the Human Immunome Project, a global non-profit working to decode the immune system in order to transform how we prevent, diagnose, and treat disease. Notable Links: Notes from a peripatetic salon across northern Thailand (Deviate episode) Hotwired (first commercial online magazine) HotBot (early web search engine) Louis Rossetto (writer, editor, and entrepreneur) Neuromancer, by William Gibson (science fiction novel) Snow Crash, by Neal Stephenson (science fiction novel) Cyberpunk (subgenre of science fiction) Electric Word (technology magazine) Digital Revolution (shift from mechanical to electronic technologies) Ethernet (computer networking technology) proto.life (newsletter covering the neobiological revolution) Neo.Life: 25 Visions for the Future of Our Species, by Jane Metcalfe (book) The Non-GMO Project (non-profit organization) David Eagleman (neuroscientist) Human genome (complete set of nucleic acid sequences for humans) Immunome (code set for proteins that constitute the immune system) Single-cell sequencing (context-driven technique for studying cells) Microbiome (community of microorganisms in a habitat) One Health (interdisciplinary approach to ecological health) Zoonotic disease (disease than can jump from non-humans to humans) Bioeconomy (use of biotechnology in the production of goods) CRISPR gene editing (technique to modify genomes of living organisms) Bioengineering (application of biology to create products) Interbeing (philosophical concept in Zen Buddhism) iGEM (worldwide synthetic biology competition) Gene drive (technology of genetic engineering) CRISPRcon (gene editing technology conference) Kevin Kelly (author and futurist) The Deviate theme music comes from the title track of Cedar Van Tassel's 2017 album Lumber. Note: We don't host a “comments” section, but we're happy to hear your questions and insights via email, at deviate@rolfpotts.com.

Advanced biotech (CRISPR gene editing, gene drives, personalized medicine) could be the most Disordering technology ever invented. Techniques like gene drives could help us eradicate malaria by sterilising mosquitoes, but could they also spell the end of humanity (by unleashing unintended consequences)? Or release a new pandemic – think COVID-19 which was likely caused by a lab lead of a manmade super virus – into the population?    While biotech offers the potential to revolutionise everything, no one has yet proposed any coherent regulations over this domain. Seeking to learn more about advances in Biotech and how they interact with AI, globalization, and climate change we are joined by Jamie Metzl. Jamie is the author of Superconvergence, and Founder and Chair of the global social movement, OneShared.World. He and Jason discuss the vast opportunities and profound threats that emanate from biotech. Jason puts forth a more socially conservative vision that we need to learn from our collective past, what Jason calls the ‘French-peasant' approach, while Jaime poopoos that approach advancing more boldly futuristic solutions.    To Order the Disorder, Jason and Alex discuss whether top-down or bottom-up governance solutions could help solve this issue, and what we need to do to regain the public's trust in experts.    Twitter: @DisorderShow    Subscribe to our Substack: https://natoandtheged.substack.com/       Producer: George McDonagh  Exec Producer: Neil Fearn    Show Notes Links  Mega-order Jamie's book, Superconvergence, at https://superconvergencebook.com/   For more on Jamie's unbelievable career: https://jamiemetzl.com/   And his novel ‘Eternal Sonata': https://www.goodreads.com/book/show/28695898-eternal-sonata   And his theories and extensive public engagement about the origins of COVID-19: https://jamiemetzl.com/origins-of-sars-cov-2/   Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode Description: Karl and Erum explore how Northern Queensland is transitioning from its historical reliance on coal mining to becoming a hub for bioeconomy. Kylie Porter, CEO of GW3 - Greater Whitsunday Alliance, shares insights on the region's rich agricultural roots, the innovative use of sugarcane in biotech, and the strategic efforts to build a sustainable future. The discussion highlights the significant role of community engagement and international collaborations in driving these changes. Tune in to hear about the exciting opportunities and challenges faced as the region redefines its economic landscape through biotechnology and sustainability initiatives. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 - Introduction to Biotech and Decarbonization 00:01:00 - Discovering the Greater Whitsundays 00:03:00 - Strategizing Economic Diversification 00:05:00 - Australia at SynBioBeta 00:07:00 - Sustainability Cuts: Nike and Beyond 00:12:00 - Innovations in Consumer Brands 00:17:00 - Interview with Kylie Porter: Transitioning to a Bioeconomy 00:20:00 - Regional Bioeconomy Efforts and Challenges 00:22:30 - The Role of Sugarcane in Biotechnology 00:25:00 - Collaborating with Queensland Government 00:27:30 - Building the First Commercial Bioeconomic Facility 00:30:00 - Engaging Influential Advocates 00:37:00 - Building Community and Ecosystems 00:42:00 - National and Regional Biotech Initiatives 00:45:00 - Tech Integration in the Coal Industry 00:49:00 - Global Collaboration and Future Prospects 00:52:00 - Sustainable Development and Decarbonization 00:57:00 - Closing Thoughts and Reflections Topics Covered: australia, mckee, coal mining, biotechnology, workforce development Episode Links: Kylie Porter on LinkedIn Caladan Bio Rebel Nation On's Spray-On Shoe Greater Whitsunday Alliance (GW3) CSIRO Commonwealth Scientific and Industrial Research Organization Australia's National Science Agency Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

On today's episode, Kristin Platts looks into a new project investigating how to make better use of the diverse agricultural waste in the Northern San Joaquin Valley.

GUEST:   https://myconaut.space/   MENTIONS:   https://advancingecoag.com/   https://www.theremediators.com/   https://zachbushmd.com/   MUSHROOM HOUR:   https://welcometomushroomhour.com   https://instagram.com/welcome_to_mushroom_hour   https://tiktok.com/@welcome_to_mushroom_hour   Show Music courtesy of the one and only Chris Peck: https://peckthetowncrier.bandcamp.com/   TOPICS COVERED:    Embracing Bioeconomy   Awakening to Soil Futures   Chemistry of PFAS   PFAS in Agriculture & Food Systems   Fungus Breaking the Carbon-Fluorine Bond   AI SymbiosisAmish Technological Wisdom   Bioleeching, Biosequestration, Bioremediation    3D Printable Fluorinated Biopolymers   Spore-Powered Ionic Plasma Thursters      Growing from a Child to an Adult Mentality   Building Data for Open Source Models   All About Partnership   Abundance Mindset   

Episode Summary Timothy Donohue, Ph.D.—ASM Past President, University of Wisconsin Foundation Fetzer Professor of Bacteriologyand Director of the Great Lakes Bioenergy Research Center (GLBRC) calls genomics a game-changer when it comes the potential of microbes to create renewable resources and products that can sustain the environment, economy and supply chain around the world. He also shares some exciting new advances in the field and discusses ways his research team is using microorganisms as nanofactories to degrade lignocellulose and make a smorgasbord of products with high economic value. Take the MTM listener survey! Ashley's Biggest Takeaways: The bioeconomy can be broadly defined as the use of renewable resources, including microorganisms, to produce valuable goods, products and services. Microbes have the potential to create products that cannot be made by existing synthetic chemistry routes. Using raw, renewable resources to create a circular bioeconomy is beneficial to the environmental footprint, economic footprint and supply chain security around the globe. Links for This Episode: The theme of our Spring 2024 Issue of Microcosm, our flagship member magazine is Microbes and the Bioeconomy: Greasing the Gears of Sustainability, launches this week and features an article based on this MTM conversation. If you are an ASM Member, check back on Wed., June 30 for the newly published content! Not a member? Consider renewing or signing up today, and begin exploring endless potential to boulster your career and network with professionals, like Donohue, in your field.  Get Bioeconomy Policy Updates. Heading to ASM Microbe 2024? Check out this curated itinerary of sessions on the bioeconomy, including those discussing the use of algae for bioproduction and synthetic biology for natural product discovery. Learn more about the Great Lakes Bioenergy Research Center. MTM listener survey!

The bioeconomy – where feedstocks from agriculture are transformed into new products – is poised to surge to more than $30 trillion dollars over the next two decades. The White House calls its potential “enormous,” and there's an organization leading the effort to create infrastructure around this opportunity. Today, BioMADE Chief Technology Officer, Melanie Tomczak, joins us to tell us 1) what exactly the bioeconomy is, 2) the role of BioMADE in its growth and 3) the unique connection between people, plants and animals. Where are the greatest opportunities for growth in bioinnovation? Melanie talks cross-sector collaboration and pushing things from early-scale to commercial scale – getting entrepreneurs out of the “Valley of Death.” She also gets into creating resilience and sustainability in U.S. supply chains in a post-pandemic world also experiencing political unrest and geo instability. What's ahead? BioMADE recently named six states (Indiana being one) to a short list of geographies that could fill a need that doesn't exist in the US today: allowing innovators to start the scale-up process without the investment into new facilities, allowing for emerging technologies and products to flow through the U.S. more quickly.

The bioeconomy – where feedstocks from agriculture are transformed into new products – is poised to surge to more than $30 trillion dollars over the next two decades. The White House calls its potential “enormous,” and there's an organization leading the effort to create infrastructure around this opportunity. Today, BioMADE Chief Technology Officer, Melanie Tomczak, joins us to tell us 1) what exactly the bioeconomy is, 2) the role of BioMADE in its growth and 3) the unique connection between people, plants and animals.  Where are the greatest opportunities for growth in bioinnovation? Melanie talks cross-sector collaboration and pushing things from early-scale to commercial scale – getting entrepreneurs out of the “Valley of Death.” She also gets into creating resilience and sustainability in U.S. supply chains in a post-pandemic world also experiencing political unrest and geo instability.  What's ahead? BioMADE recently named six states (Indiana being one) to a short list of geographies that could fill a need that doesn't exist in the US today: allowing innovators to start the scale-up process without the investment into new facilities, allowing for emerging technologies and products to flow through the U.S. more quickly. 

Recorded at SCbio's 2024 annual conference, hosts Heather and Matthew welcome Sarah Glaven, a research biologist and the Assistant Director of Biotechnology and Biomanufacturing for The White House Office of Science and Technology Policy. We have an insightful conversation on America's bioeconomy and bioliteracy and dive into President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bio economy, which established the National Biotechnology and Biomanufacturing Initiative or NBBI. Listen to episode 185 now!

Wain Collen, co-founder and executive director of Fundación Aliados in Ecuador, joins Scott Stone, Marlies Quirino, and Lucia Guaita on The Lookfar Podcast: Voices from the Wild. Aliados's work is centered on four pillars – practicing regenerative agriculture, incubating bioeconomy initiatives, connecting to responsible markets, and creating new ecological value. Aliados just launched the Center for Bioeconomy with eleven indigenous and local community organizations, spearheading an innovative investment hub in the Ecuadorian Amazon to scale resilient community-led businesses. A fascinating discussion with Wain about Aliados' remarkable work. Available on all major podcast platforms. Just search Lookfar and you'll find it! 

Episode Description: Today we are discussing the innovative intersection of synthetic biology and blockchain technology with Albert Anis, the visionary behind ValleyDAO. Anis shares his ambitious dream of creating a bioeconomy that is not owned by any single entity but is collectively governed by a community. Through the lens of ValleyDAO, we explore how decentralized autonomous organizations (DAOs) can fund, support, and propel scientific research in biotechnology, bringing it closer to the mainstream and potentially revolutionizing the way we approach the bioeconomy. Anis' passion for creating a shared, decentralized future where discoveries in synthetic biology can be accessed and benefited from by all shines through, offering a glimpse into a future where biology and technology merge for the greater good. For everyone who is intrigued by the potential of blockchain to transform the scientific landscape and democratize access to biotechnological advancements, this episode is for you! Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠www.messaginglab.com/groweverything⁠ Chapters: 00:00:00 - The Beat of Innovation: Medieval Hip Hop's Creative Pulse 00:01:42 - A Night of Glamour and Discovery: Oscars Through a Biotech Lens 00:03:20 - Cinema Meets Science: The Biological Undercurrents of Blockbusters 00:04:49 - Crafting Content with Purpose: Beyond Clickbait to Meaningful Messages 00:06:53 - AI's Leap into Biology: Accelerating Insights and Transformations 00:10:44 - ValleyDAO's Launch: Pioneering the Biotech Blockchain Fusion 00:12:56 - Albert Anis' Journey: Bridging Biotech Enthusiasm with Blockchain 00:19:56 - Inspiration from ConstitutionDAO: A Community's Power in Unity 00:26:10 - Inside ValleyDAO: Democratizing Biotech Funding 00:29:26 - Finding the Future: Selecting Groundbreaking Biotech Projects 00:32:30 - Yeast on the Frontier: Pioneering Research for a Sustainable Future 00:34:46 - Bridging Lab to Life: How ValleyDAO Moves Ideas to Impact 00:38:12 - The Heart of ValleyDAO: Cultivating a Committed Community 00:44:52 - Structuring Success: The Legal Backbone of a Decentralized Dream 00:50:15 - Visionary Horizons: Shaping the Bioeconomy with ValleyDAO 00:52:56 - Looking Back, Moving Forward: Reflections on a Biotech-Blockchain Alliance Episode Links: Join ValleyDAO - synbio for climate (link iGEM - synbio competition (link) Interview with Jocelyn Pearl of LabDAO (link) Interview with Arye Lipman of LabDAO (link) LabDAO for computational biology (link) HairDAO for hair loss  (link) AthenaDAO for women's health (link) MoleculeDAO for drug development (link) Messaginglab blog (link) Get $300 off ⁠⁠⁠⁠Synbiobeta tickets⁠⁠⁠⁠ (May 6-9 in San Jose, CA) using promo code: Grow Everything Topics Covered:  biomaterials, sustainability, biodegradablility, compostibility Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Support here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

Episode 82. Alexander Titus is a professor at USC, doing research at the intersection of biology and AI. He completed his PhD in Quantitative Biomedical Sciences at Dartmouth. He's also the founder of Bioeconomy.xyz and advises the U.S. Government on AI and national security. Titus spent time at McKinsey and Google and helped build Colossal Biosciences and Form Bio.